• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Preventive Medicine: An International Journal Devoted to Practice and Theory >The economic value of reductions in gonorrhea and syphilis incidence in the United States, 1990-2003.
【24h】

The economic value of reductions in gonorrhea and syphilis incidence in the United States, 1990-2003.

机译：1990年至2003年，美国淋病和梅毒发病率降低的经济价值。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

BACKGROUND: Prevention efforts can reduce the considerable health and economic burdens imposed by sexually transmitted diseases (STDs). The objective of this study was to estimate the reduction in direct medical costs associated with reductions in gonorrhea and syphilis incidence in the United States from 1990 to 2003. METHODS: Using published estimates of the per-case costs of STDs, we estimated the annual costs from 1990 to 2003 of four main outcomes: primary and secondary (P&S) syphilis, congenital syphilis, gonorrhea, and HIV costs attributable to the facilitative effects of gonorrhea and syphilis on HIV transmission and acquisition. RESULTS: Reductions in syphilis and gonorrhea from 1990 to 2003 have saved an estimated 5.0 billion dollars (in 2003 U.S. dollars): 1.1 billion dollars in costs associated with P&S syphilis, congenital syphilis, and gonorrhea, and 3.9 billion dollars in HIV costs attributable to syphilis and gonorrhea. In additional analyses, the estimated reductions in disease burden were substantially lower (1) when calculated incrementally (rather than cumulatively) and (2) when long-term costs of STDs were excluded. CONCLUSIONS: These estimated reductions in the burden of gonorrhea and syphilis show the economic benefits of reducing the incidence of these STDs and preventing their resurgence.
机译：背景：预防工作可以减少性传播疾病（STD）带来的巨大健康和经济负担。这项研究的目的是估计1990年至2003年美国与淋病和梅毒发生率降低相关的直接医疗费用的减少。方法：使用已公布的性病每例费用的估计值，我们估算了年度费用从1990年到2003年有四个主要结局：原发性和继发性梅毒，先天性梅毒，淋病，以及由于淋病和梅毒对HIV传播和获取的促进作用而导致的HIV费用。结果：从1990年到2003年，梅毒和淋病的减少估计节省了50亿美元（按2003年美元计算）：与P＆S梅毒，先天性梅毒和淋病相关的费用为11亿美元，归因于艾滋病的费用为39亿美元梅毒和淋病。在其他分析中，估计的疾病负担减轻幅度要低得多（1）以递增方式（而不是累计方式）计算，并且（2）在不计入性病长期成本的情况下。结论：这些估计的淋病和梅毒负担的减轻显示出减少这些性病的发生并防止其复发的经济利益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号